Skip to main content

Meet the Analyst: Thomas Wakim & John Hester, Bell Potter Analyst

Bell Direct
December 17, 2024

Join us as we conclude our 2024 Meet the Analyst series with a bang. Our Market Analyst, Grady Wulff, sits down with Bell Potter’s analysts John Hester and Thomas Wakim for a comprehensive discussion on the healthcare sector.

From deciphering Neuren Pharmaceuticals (ASX:NEU) share price fluctuations to anticipating the news flow that will share 2025 guidance and identifying why Telix Pharmaceuticals (ASX:TLX) and Clarity Pharmaceuticals (ASX:CU6) are stocks to watch in the new year, John and Thomas cover it all in this final episode of the year.

In this video, John and Thomas discuss:

  • (1:48): the headwinds & tailwinds facing the healthcare sector
  • (7:10): why they are bullish on Neuren
  • (13:48): opportunities in healthcare stocks for 2025
  • (15:18): what’s on their clinical data radar for the upcoming year.

Market Update 19 March

Jessica Amir
March 19, 2020

Morning Bell 18 March

Jessica Amir
March 18, 2020

Morning Bell 17 March

Jessica Amir
March 17, 2020

Market Update 16 March

Bell Direct
March 16, 2020

Weekly Wrap 13 March

Jessica Amir
March 13, 2020

Market Update 12 March

Paulina Peters
March 12, 2020

Morning Bell 11 March

Jessica Amir
March 11, 2020

ETF mini-series 3/3: Top ETF picks

Jessica Amir
March 10, 2020

Morning Bell 10 March

Jessica Amir
March 10, 2020